AI
| Followers | 376 |
| Posts | 17210 |
| Boards Moderated | 3 |
| Alias Born | 03/07/2014 |
Friday, April 24, 2015 12:38:20 PM
LOL, it's not even a 52 week or 2 YEAR high right now???
What's the big "excitement" that this is some "unprecedented" supposed "big buying" never seen before, blah blah? Look at the 2 YEAR chart- it traded higher than this MANY times as an OTC penny stinker. This isn't even a 52 week high, let alone even a sustained near-term high yet. It's gone to these levels many, many, many times in more than the past 2 years only to give it all back and then some.
They haven't even diluted yet- they have nowhere near the cash yet IMO to fund a major phase II, large, FDA quality trial and they have not even started the trial(s) yet- the one's that were stated to "hopefully" be well underway by END OF 2014. It's about to hit MID 2015 in a month or two here- and they got a goose egg sitting in the "new trials" box. The $62 million secondary failed and was pulled. They filed for $100 MILLION dollars and stated they had plans to use it all- meaning IMO that's the kind of coin they figured they'd need for running serious phase II trial(s).
That's a TWO YEAR chart- the old OTC days most of it- and it traded at these levels numerous times, what's the biggy here so far??
Here's another one with THREE YEARS of trading history:
It hasn't even reached sustained levels where it traded on the OTC, YEARS ago. Not sure what all the "excitement" is here yet? Lincoln has likely taken a breather from selling dilution shares- look at the historical charts, a normal pattern to let it come up for a "breather" between selling into strength as OCAT makes continual "draw-downs" on the dilutive credit line facility.
Nothing new here yet IMO. Same old.
What's the big "excitement" that this is some "unprecedented" supposed "big buying" never seen before, blah blah? Look at the 2 YEAR chart- it traded higher than this MANY times as an OTC penny stinker. This isn't even a 52 week high, let alone even a sustained near-term high yet. It's gone to these levels many, many, many times in more than the past 2 years only to give it all back and then some.
They haven't even diluted yet- they have nowhere near the cash yet IMO to fund a major phase II, large, FDA quality trial and they have not even started the trial(s) yet- the one's that were stated to "hopefully" be well underway by END OF 2014. It's about to hit MID 2015 in a month or two here- and they got a goose egg sitting in the "new trials" box. The $62 million secondary failed and was pulled. They filed for $100 MILLION dollars and stated they had plans to use it all- meaning IMO that's the kind of coin they figured they'd need for running serious phase II trial(s).
That's a TWO YEAR chart- the old OTC days most of it- and it traded at these levels numerous times, what's the biggy here so far??
Here's another one with THREE YEARS of trading history:
It hasn't even reached sustained levels where it traded on the OTC, YEARS ago. Not sure what all the "excitement" is here yet? Lincoln has likely taken a breather from selling dilution shares- look at the historical charts, a normal pattern to let it come up for a "breather" between selling into strength as OCAT makes continual "draw-downs" on the dilutive credit line facility.
Nothing new here yet IMO. Same old.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
